Your Client Rank:
Loading...
99
Updated 01-Jun-2023
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Novo | 15.4% | 0.2% | -1.2% | 0.6% | 2.1% | 0.9% | 18.2% | 19.5% |
| Lilly | 14.6% | 0.7% | -6.5% | -5.7% | 9.5% | 5.9% | 24.3% | 24.7% |
| Daiichi | 12.2% | 2.3% | 0.8% | -5.7% | 20.0% | 12.3% | 30.2% | 30.2% |
| Eisai | 8.5% | 1.5% | 0.1% | -5.3% | 25.0% | | 19.8% | 19.8% |
| Vertex | 7.7% | 0.3% | 2.3% | 1.9% | -0.9% | 0.8% | 7.6% | 7.3% |
| Astra | 5.2% | 0.2% | -1.6% | 0.5% | 6.4% | 4.0% | 12.1% | 10.9% |
| Regeneron | 4.7% | -0.2% | 1.0% | 1.0% | -2.4% | -1.2% | 3.3% | 2.8% |
| Sanofi | 4.4% | 0.8% | -2.6% | -1.7% | 4.4% | -0.2% | 5.9% | 6.7% |
| Merck | 4.0% | 1.5% | -0.7% | -0.5% | 3.5% | 3.0% | 7.8% | 8.0% |
| Lundbeck | 3.4% | 0.7% | -1.1% | -1.9% | 6.0% | 1.0% | 6.7% | 7.4% |
| Glaxo | 3.4% | 1.0% | 0.2% | 0.8% | 4.7% | 0.3% | 7.4% | 6.0% |
| Novartis | 3.1% | 0.1% | -1.9% | -0.3% | 2.4% | 0.6% | 6.1% | 8.3% |
| JnJ | 3.1% | 0.0% | -1.0% | -0.7% | 0.9% | 1.1% | 3.3% | 4.3% |
| Astellas | 2.9% | -0.1% | -3.4% | -0.7% | 6.0% | 0.3% | 9.4% | 11.1% |
| Roche | 2.8% | 0.9% | -0.5% | 0.3% | 1.4% | 1.3% | 4.8% | 4.8% |
| Amgen | 2.8% | -0.1% | -0.2% | 0.9% | 0.2% | 3.6% | 3.7% | 3.7% |
| Gilead | 1.9% | -0.2% | -1.0% | -0.6% | 0.3% | 0.7% | 2.5% | 3.0% |
| AbbVie | 1.4% | -0.1% | 0.5% | 0.4% | -0.4% | 3.2% | 0.9% | 1.3% |
| Teva | 1.2% | 0.1% | -0.4% | 1.2% | 0.8% | 7.1% | 3.3% | 2.5% |
| Bayer | 0.7% | 0.2% | -1.7% | -0.6% | 6.3% | 16.4% | 1.4% | 0.4% |
| Biogen | 0.4% | 1.1% | -1.2% | -0.7% | 3.6% | 0.6% | 3.6% | 5.0% |
| Takeda | 0.4% | 0.1% | -0.8% | 1.3% | 6.4% | 9.7% | -0.4% | 7.8% |
| Bristol | 0.1% | -0.8% | -1.6% | -1.2% | 0.7% | 1.8% | 0.1% | 1.5% |
| Viatris | -0.5% | 0.3% | -0.7% | 8.7% | -1.1% | 0.8% | -0.1% | 0.8% |
| Chugai | -0.6% | 3.4% | 2.3% | 5.4% | 2.6% | -2.2% | 3.0% | 3.0% |
| Shionogi | -1.7% | -0.1% | 0.3% | -4.8% | 2.3% | 7.0% | -3.9% | -3.1% |
| Pfizer | -7.5% | 2.7% | 10.6% | 9.4% | -3.6% | 5.3% | -11.3% | -11.0% |
| EU Major | 4.4% | 0.8% | -1.3% | -0.1% | 4.1% | 2.2% | 7.9% | 6.9% |
| Other EU | 3.4% | 0.7% | -1.1% | -1.9% | 6.0% | 1.0% | 6.7% | 7.4% |
| US Major | 1.4% | 0.9% | 1.0% | 1.2% | 0.8% | 3.1% | 1.7% | 6.7% |
| US Big Biotech | 3.1% | 0.1% | -0.7% | 0.7% | 0.1% | 1.5% | 3.8% | 4.1% |
| Other US | 0.3% | 0.2% | -0.5% | 4.8% | -0.3% | 3.0% | 1.3% | 1.6% |
| Japanese | 3.3% | 1.1% | 0.3% | -0.7% | 6.6% | 4.6% | 5.2% | 7.0% |
